defense sbir sttr innovation portal dsip Department of 2014.3 DoW Office for Small Business

The first cardiovascular study of NNMT enzyme inhibition in a heart failure with preserved ejection fraction (HFpEF) mouse model demonstrated that treatment markedly reduced 1-MNA (by 77.1%), 2PY (by 66.2%), and 4PY (by 71.1%) in cardiac tissue, while improving cardiac function, enhancing global longitudinal strain, reversing peak longitudinal strain rate, and significantly reducing left ventricular hypertrophy and fibrosis

This targeted mechanism positions it as a valuable research compound for studying appetite regulation, gastric signaling, and metabolic control pathways

Vormann J, Goedecke T

Research Use Only: The statements made within this website have not been evaluated by the US Food and Drug Administration